OBGC
MEDP icon

O'Brien Greene & Co’s Medpace MEDP Stock Holding History

O'Brien Greene & Co’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-12,743
Closed -$7.16M – 141
2025
Q4 		$7.16M Buy
12,743
+80
+0.6% +$45.4K 2.12% 20
2025
Q3 		$6.51M Sell
12,663
-109
-0.9% -$47.6K 2% 21
2025
Q2 		$4.01M Buy
12,772
+397
+3% +$119K 1.31% 25
2025
Q1 		$3.77M Sell
12,375
-462
-4% -$155K 1.26% 27
2024
Q4 		$4.26M Buy
+12,837
New +$4.35M 1.38% 29

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

O'Brien Greene & Co's MEDP Position: Q1 2026 in Review

O'Brien Greene & Co sold out of Medpace (MEDP) in Q1 2026, closing a stake of 12,743 shares — an estimated $7.16M sold.

O'Brien Greene & Co first reported a position in MEDP in Q4 2024 and held it in 5 quarters. The position peaked at $7.16M in Q4 2025. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • O'Brien Greene & Co reported no remaining Medpace position as of Q1 2026 after selling out during the quarter.
  • O'Brien Greene & Co sold 12,743 Medpace shares in Q1 2026, an estimated $7.16M.
  • O'Brien Greene & Co first reported a position in Medpace in Q4 2024 and held it in 5 quarters.
  • O'Brien Greene & Co's Medpace position peaked at $7.16M in Q4 2025.
  • 729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on O'Brien Greene & Co's 13F filing for Q1 2026, filed 6 May 2026.